Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -4 of 4 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		R1507 in Patients With Recurrent or Refractory Sarcomas

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				12 and over				Other				2007-0515 NCT00615680


2.		A Study of the Effect of R1507 in Combination With Tarceva (Erlotinib) on Progression-Free Survival in Patients With Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Approved-not yet active				18 and over				Pharmaceutical / Industry				NO21160 2008-001736-12, NCT00760929


3.		A Multiple Ascending Dose Study of R1507 in Patients With Advanced Solid Tumors.

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Biomarker/Laboratory analysis, Treatment				Active				18 and over				Pharmaceutical / Industry				BO19373 NCT00400361


4.		A Multiple Ascending Dose Study of R1507 in Children and Adolescents With Advanced Solid Tumors.

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Active				2 to 17				Pharmaceutical / Industry				NO21200 NCT00560144

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute